|
|
|
| Webinar: A New Look at Subcutaneous mAb Delivery Using Nanoformed Particles | Subcutaneous (Sub-Q) delivery offers self-administration and fewer hospital visits but is challenging for high-dose biologics. Nanoform developed a concentrated, non-aqueous Sub-Q IgG1 suspension using its patented dry particle platform. The study evaluated particle size impact, formulation properties, protein quality, and stability, with pharmacokinetic studies ongoing. Key topics include Sub-Q benefits, Nanoform’s dry particle process, and non-aqueous suspension formulation. Click here to learn more. |
|
|
|
|
Early Solid Form Screening To Guide Drug Development | Article | By Abhijeet S. Sinha, Lonza | Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road. |
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Lynn Cinelli, VP Global Biologics Supply Chain at Bristol Myers Squibb, has been strategizing on why Pharma is so poor at forecasting demand. "The entities that feel the pressures most may be our CDMOs,” she says. She has a better way to go about it — and it starts with the patient. | |
|
|
The Expanding Role Of CMC In Biotech Investor Decision-Making | By Nathalie Huther, Ph.D., MBA and Carlos N Velez, Ph.D., MBA | With increasingly complex modalities, undruggable targets, rare diseases, and narrowly defined patient subpopulations, CMC is an important area of due diligence scrutiny for prospective investors and licensees. Part 1 of a two-part analysis. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
|
Medicinal Chemistry — India | Pharma Expanse | Our business model doesn't add additional costs to your project. Review our network's medicinal chemistry capabilities and contact us to simplify your outsourcing solutions. |
|
|
Nasal Spray Development And Manufacturing Services | Catalent | A partner with experts who are adept at working with complex, sensitive, and potent APIs; screening for the optimal formulation; and scaling up efficiently is vital for successful trials and commercialization. |
|
|
South Haven cGMP Manufacturing Services And APIs | Grace Fine Chemical Manufacturing Services | Learn how our chemical manufacturing facilities are equipped to support a wide range of projects with on-site pilot plants and large-scale commercial capabilities for manufacturing high-quality APIs. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
